BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20498076)

  • 1. Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance.
    Garbuzenko OB; Saad M; Pozharov VP; Reuhl KR; Mainelis G; Minko T
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10737-42. PubMed ID: 20498076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA.
    Taratula O; Kuzmov A; Shah M; Garbuzenko OB; Minko T
    J Control Release; 2013 Nov; 171(3):349-57. PubMed ID: 23648833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system.
    Pakunlu RI; Wang Y; Tsao W; Pozharov V; Cook TJ; Minko T
    Cancer Res; 2004 Sep; 64(17):6214-24. PubMed ID: 15342407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA.
    Taratula O; Garbuzenko OB; Chen AM; Minko T
    J Drug Target; 2011 Dec; 19(10):900-14. PubMed ID: 21981718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice.
    Mainelis G; Seshadri S; Garbuzenko OB; Han T; Wang Z; Minko T
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):345-54. PubMed ID: 23530772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.
    Saad M; Garbuzenko OB; Minko T
    Nanomedicine (Lond); 2008 Dec; 3(6):761-76. PubMed ID: 19025451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.
    Wang Y; Saad M; Pakunlu RI; Khandare JJ; Garbuzenko OB; Vetcher AA; Soldatenkov VA; Pozharov VP; Minko T
    Clin Cancer Res; 2008 Jun; 14(11):3607-16. PubMed ID: 18519795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug.
    Pakunlu RI; Wang Y; Saad M; Khandare JJ; Starovoytov V; Minko T
    J Control Release; 2006 Aug; 114(2):153-62. PubMed ID: 16889867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.
    Pakunlu RI; Cook TJ; Minko T
    Pharm Res; 2003 Mar; 20(3):351-9. PubMed ID: 12669953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
    Nasser MW; Datta J; Nuovo G; Kutay H; Motiwala T; Majumder S; Wang B; Suster S; Jacob ST; Ghoshal K
    J Biol Chem; 2008 Nov; 283(48):33394-405. PubMed ID: 18818206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
    Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meloxicam increases intracellular accumulation of doxorubicin via downregulation of multidrug resistance-associated protein 1 (MRP1) in A549 cells.
    Chen SF; Zhang ZY; Zhang JL
    Genet Mol Res; 2015 Nov; 14(4):14548-60. PubMed ID: 26600514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
    Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
    Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
    Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
    Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
    Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
    Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
    Lo YL; Liu Y; Tsai JC
    Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
    Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH
    Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats.
    Gaspar MM; Radomska A; Gobbo OL; Bakowsky U; Radomski MW; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):310-8. PubMed ID: 22857016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.